1. Home
  2. GHRS vs GNE Comparison

GHRS vs GNE Comparison

Compare GHRS & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • GNE
  • Stock Information
  • Founded
  • GHRS 2018
  • GNE 2011
  • Country
  • GHRS Ireland
  • GNE United States
  • Employees
  • GHRS N/A
  • GNE N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • GNE Power Generation
  • Sector
  • GHRS Health Care
  • GNE Utilities
  • Exchange
  • GHRS Nasdaq
  • GNE Nasdaq
  • Market Cap
  • GHRS 462.0M
  • GNE 421.6M
  • IPO Year
  • GHRS 2021
  • GNE N/A
  • Fundamental
  • Price
  • GHRS $8.99
  • GNE $14.86
  • Analyst Decision
  • GHRS Strong Buy
  • GNE
  • Analyst Count
  • GHRS 3
  • GNE 0
  • Target Price
  • GHRS $35.67
  • GNE N/A
  • AVG Volume (30 Days)
  • GHRS 89.4K
  • GNE 74.0K
  • Earning Date
  • GHRS 02-27-2025
  • GNE 03-10-2025
  • Dividend Yield
  • GHRS N/A
  • GNE 2.01%
  • EPS Growth
  • GHRS N/A
  • GNE N/A
  • EPS
  • GHRS N/A
  • GNE 0.12
  • Revenue
  • GHRS N/A
  • GNE $427,221,000.00
  • Revenue This Year
  • GHRS N/A
  • GNE N/A
  • Revenue Next Year
  • GHRS N/A
  • GNE N/A
  • P/E Ratio
  • GHRS N/A
  • GNE $122.80
  • Revenue Growth
  • GHRS N/A
  • GNE 5.44
  • 52 Week Low
  • GHRS $5.92
  • GNE $14.00
  • 52 Week High
  • GHRS $14.99
  • GNE $20.33
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 58.18
  • GNE 46.70
  • Support Level
  • GHRS $8.02
  • GNE $14.54
  • Resistance Level
  • GHRS $10.23
  • GNE $15.70
  • Average True Range (ATR)
  • GHRS 0.90
  • GNE 0.36
  • MACD
  • GHRS 0.11
  • GNE -0.02
  • Stochastic Oscillator
  • GHRS 62.20
  • GNE 35.46

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

Share on Social Networks: